Medical Properties Trust, Inc. v. Viceroy Research, LLC

CourtDistrict Court, N.D. Alabama
DecidedJune 29, 2023
Docket2:23-cv-00408
StatusUnknown

This text of Medical Properties Trust, Inc. v. Viceroy Research, LLC (Medical Properties Trust, Inc. v. Viceroy Research, LLC) is published on Counsel Stack Legal Research, covering District Court, N.D. Alabama primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Medical Properties Trust, Inc. v. Viceroy Research, LLC, (N.D. Ala. 2023).

Opinion

UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ALABAMA SOUTHERN DIVISION

MEDICAL PROPERTIES TRUST, INC., } } Plaintiff, } } v. } Case No.: 2:23-cv-00408-RDP } VICEROY RESEARCH, et al., } } Defendants. }

MEMORANDUM OPINION

I. Introduction

This action is before the court on Defendants Viceroy Research (“Viceroy”) and Fraser Perring’s 12(b)(2) Motion to Dismiss (Doc. # 16) and Defendant Viceroy’s 12(b)(6) Motion to Dismiss. (Doc. # 17). Defendants’ Motions have been fully briefed (Docs. # 16, 34, 40 and 17, 33, 39, respectively) and are ripe for review. After careful review, and for the reasons discussed below, Defendants’ 12(b)(2) Motion (Doc. # 16) is due to be denied, and Viceroy’s 12(b)(6) Motion (Doc. # 17) is due to be granted in part and denied in part. II. Background This case arises out of Defendants Viceroy, Perring, Gabriel Bernarde, and Aidan Lau’s (collectively “Defendants” or “Individual Defendants” when referencing Perring, Bernarde, and Lau) alleged efforts to manipulate Plaintiff Medical Properties Trust’s (“Plaintiff” or “MPT”) stock price in order to profit on its short position. On March 30, 2023, Plaintiff filed this action alleging defamation and other state law claims A. MPT’s Business Practices Plaintiff MPT is a real estate investment trust (“REIT”) that acquires, develops, and invests in healthcare facilities. (Doc. # 1 ¶ 10). MPT has long been one of Alabama’s largest and most prominent publicly traded companies, and its largest REIT. (Id. ¶ 1). MPT acquires and develops healthcare facilities to lease out to operating companies under long-term net leases, which require

tenants to bear most of the costs associated with the properties. (Id. ¶ 20). A typical lease provides for a term of at least 15 years with a series of short renewal options. (Id. ¶ 22). MPT’s business model is centered around steady, long-term returns for its investors. (Id. ¶ 24). To that end, MPT underwrites real estate investments that are attractive to hospital operators, so that if one operator must break its lease, a replacement operator will soon assume the lease. (Id.). Among the characteristics MPT looks for in evaluating hospital real estate are: (1) good physical quality reflecting a history of maintenance and improvements; (2) location in a strong market, with measurable patient demand growth, sustainable reimbursement sources, and features that attract a dedicated workforce; (3) a geographic environment in which the operator is likely to hold a strong competitive position; and (4) facility-level operations with strong EBITDARM (earnings before interest, taxes, depreciation, amortization, rent, and management fees) coverage of lease payments.

(Id.). MPT reasons that a medical facility meeting these criteria is likely to reflect a true “community need,” meaning its success is not dependent on a given operator. (Id.). For example, in 2016 and 2018, MPT purchased nine Massachusetts hospitals from hospital operator Steward Health Care System for approximately $1.3 billion. (Id. ¶ 25). In 2022, private equity firm Macquarie Asset Management entered into a joint venture with MPT for eight of those Massachusetts hospitals, which had a total valuation of about $1.7 billion, an increase in value over the purchase price of some $400 million. In the interim, those hospitals had yielded about $475 million in income for MPT. (Id.). This is MPT’s bread and butter: invest in an attractive facility, generate income from that facility, then sell the facility for a profit. MPT currently has investments in 444 facilities, the vast majority of which are leased to 55 tenants. (Id. ¶ 26). Its revenues exceeded $1.5 billion in 2022, making it “one of the largest REITS in the healthcare sector and among the largest publicly traded companies in Alabama, where the majority of its employees are located.” (Id.). MPT has retained PricewaterhouseCoopers (“PwC”) as its independent auditor since 2008. (Id. ¶ 28). Every year since 2008, “PwC has issued

an unqualified opinion that MPT’s financial statements ‘present fairly, in all material respects, the financial position of’ the Company and ‘the results of its operations and its cash flows’ for the relevant periods in conformity with generally accepted accounting principles.” (Id. ¶ 29). B. Short-Selling and Short-and-Distort Campaigns Taking a short position involves a bet that a stock’s price will fall. A trader takes a short position by “sell[ing] a security first with the intention of repurchasing … later at a lower price.” James Chen, Short Position: Meaning, Overview, and FAQs, Investopedia (Sept. 12, 2022) https://www.investopedia.com/terms/s/short.asp. Because a stock’s price can never fall below $0, the short-seller’s potential profit is capped. But, because there is no limit to how high a stock price

may rise, short sellers “face unlimited downside risk.” (See id.). Because the risk inherent in short selling is so high, some short sellers engage in “short- and-distort” campaigns. (Doc. # 1 ¶ 31). That is, they “publish[] … or otherwise promoting false and misleading information about the companies they bet against.” (Id.). Doing so allows short sellers to “drive down those companies’ stock prices and generate profit for themselves.” (Id.). The Securities and Exchange Commission has recently proposed a rule designed in part to combat these illegal short-and-distort campaigns. 87 F.R. 14950, 14991-94 (Mar. 16, 2022) (“[I]f short and distort type behavior were to be suspected, then the Commission would be more likely to identify individuals with large short positions and could thus quickly focus any inquiries on entities in an economic position to potentially profit from manipulation.”). C. Viceroy and the Individual Defendants’ Accusations Against MPT Defendant Viceroy is a financial research firm founded by Fraser Perring, a citizen of the United Kingdom, along with Gabriel Bernarde and Aidan Lau, both Australian citizens. (Id. ¶ 11).

On January 26, 2023, Viceroy published a report titled “Medical Properties (dis)Trust,” in which it noted that it had a short position in MPT. (Doc. # 1 ¶ 41). That same day, Viceroy and the Individual Defendants began using their Twitter accounts to promote their report and otherwise criticize MPT. (Id. ¶ 42). Defendants went on to publish 13 more reports on MPT, purportedly consisting of research on MPT’s business practices. (Id.). In each of these reports, and in a February 2, 2023 letter Defendants published to Twitter, Viceroy claims to have analyzed and found wanting “the accounting treatment MPT has applied in its financial statements.” (Id. ¶ 43). MPT identifies four categories of misrepresentations that it asserts subject Defendants to liability: (1) false accusations of “round-tripping;” (2) false characterizations of MPT’s executive

compensation formula; (3) false accusations of lying about dealings with operator-tenant Steward; and (4) false accusations of fraud and criminal activity. (Id. ¶ 45). 1. Round-Tripping Round-tripping occurs when a party transacts with a counterparty to provide funds with the understanding that the counterparty will later return those funds in a second transaction. (Id. ¶ 46). The original party then records the returned funds as revenue. (Id.). For example, A agrees to sell B a pencil for $1. At the outset, both parties agree that A will later purchase the same pencil from B for the same price at which A sold it. When A re-purchases the pencil from B, B records a $1 revenue infusion despite no additional revenue going into its coffers. Plaintiff provides several examples of Defendants accusing it of round-tripping. (Id. at ¶¶ 47-54).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Consolidated Development Corp. v. Sherritt, Inc.
216 F.3d 1286 (Eleventh Circuit, 2000)
Watts v. Florida International University
495 F.3d 1289 (Eleventh Circuit, 2007)
Licciardello v. Lovelady
544 F.3d 1280 (Eleventh Circuit, 2008)
Oldfield v. Pueblo De Bahia Lora, S.A.
558 F.3d 1210 (Eleventh Circuit, 2009)
United Technologies Corp. v. Mazer
556 F.3d 1260 (Eleventh Circuit, 2009)
Fraser v. Smith
594 F.3d 842 (Eleventh Circuit, 2010)
Milliken v. Meyer
311 U.S. 457 (Supreme Court, 1941)
International Shoe Co. v. Washington
326 U.S. 310 (Supreme Court, 1945)
McGee v. International Life Insurance
355 U.S. 220 (Supreme Court, 1957)
Hanson v. Denckla
357 U.S. 235 (Supreme Court, 1958)
New York Times Co. v. Sullivan
376 U.S. 254 (Supreme Court, 1964)
Gertz v. Robert Welch, Inc.
418 U.S. 323 (Supreme Court, 1974)
World-Wide Volkswagen Corp. v. Woodson
444 U.S. 286 (Supreme Court, 1980)
Keeton v. Hustler Magazine, Inc.
465 U.S. 770 (Supreme Court, 1984)
Calder v. Jones
465 U.S. 783 (Supreme Court, 1984)
Burger King Corp. v. Rudzewicz
471 U.S. 462 (Supreme Court, 1985)
Keller v. State Bar of California
496 U.S. 1 (Supreme Court, 1990)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)

Cite This Page — Counsel Stack

Bluebook (online)
Medical Properties Trust, Inc. v. Viceroy Research, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/medical-properties-trust-inc-v-viceroy-research-llc-alnd-2023.